Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.920
0.00 (0.00%)
Oct 31, 2024, 4:00 PM EDT - Market closed

Boundless Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21
Net Income
-57.72-49.43-45.9-25.21
Depreciation & Amortization
1.010.960.940.68
Loss (Gain) From Sale of Investments
-5.16-3.30.50.54
Stock-Based Compensation
5.263.342.291.16
Other Operating Activities
2.542.391.70.42
Change in Accounts Payable
2.441.661.911.22
Change in Other Net Operating Assets
-4.25-2.46-1.05-2.06
Operating Cash Flow
-55.89-46.86-39.6-23.25
Capital Expenditures
-2.01-0.63-1.07-2.03
Investment in Securities
-39.95-37.6317.2-57.25
Investing Cash Flow
-41.96-38.2616.13-59.29
Issuance of Common Stock
93.180.180.130.21
Other Financing Activities
-4.96-1.96--
Financing Cash Flow
87.8997.90.13105.53
Net Cash Flow
-9.9512.78-23.3422.99
Free Cash Flow
-57.89-47.49-40.66-25.28
Free Cash Flow Per Share
-8.99-39.05-37.04-29.38
Levered Free Cash Flow
-36.04-30.95-24.76-
Unlevered Free Cash Flow
-36.04-30.95-24.76-
Change in Net Working Capital
-0.340.36-2.12-
Source: S&P Capital IQ. Standard template. Financial Sources.